Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm, Residual × Liquid Biopsy × Sarcoma × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 2 Tumor-Agnostic 1 Sarcoma 1

Conditions

Sarcoma, Ewing 1 Neurofibrosarcoma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm, Residual 1 Gastrointestinal Stromal Tumors 1

Interventions

Liquid Biopsy 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05408897 2022-09-21

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

Peking University People's Hospital

GastrointestinalSarcoma

Neoplasm, Residual, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡